Fierce Pharma September 30, 2024
Sponsored By Phreesia

Patients with rare or complex diseases often struggle to find specialists who meet their specific condition and individual needs. But care delays can negatively impact health outcomes, especially in diseases that are progressive in nature, including multiple sclerosis (MS) and other autoimmune disorders, cancer and many rare conditions.

The solution? Meet patients in more impactful ways during their doctor search.

It’s crucial to connect patients with relevant information on symptoms and conditions when they are most in need of answers – before they receive a diagnosis. Doing so can help get someone to the right doctor to make a diagnosis and keep them on the path to effective treatment, explain Katherine Perez, VP Global Patient Advocacy and Policy, and Susan...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article